ArticleScientific reports2025

In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia.

Raúl Córdoba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.